# Green Plains Inc.: financial statements, quarterly

GPRE · Nasdaq · CIK 1309402 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gpre.md) · [Financials](/companies/gpre/financials.md) · [Filings](/companies/gpre/filings.md) · [Insiders](/companies/gpre/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gpre/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [32.9](/filings/0001309402-24-000129.md) | [31.5 d](/filings/0001309402-26-000019.md) | [41.6](/filings/0001309402-25-000089.md) | [41.1](/filings/0001309402-25-000130.md) | [39.1](/filings/0001309402-25-000163.md) | [41.2 d](/filings/0001309402-26-000019.md) | [35.8](/filings/0001309402-26-000060.md) | [66.2](/filings/0001628280-26-054377.md) | [44.7](/filings/0001309402-25-000163.md) | [42.2 d](/filings/0001309402-26-000019.md) | [42.7](/filings/0001309402-26-000060.md) | [45.9](/filings/0001628280-26-054377.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | [74.8](/filings/0001309402-24-000129.md) | [73.8 d](/filings/0001309402-26-000019.md) | [8.4](/filings/0001309402-25-000089.md) | [37.8](/filings/0001309402-25-000130.md) | [78.1](/filings/0001309402-25-000163.md) | [6.2 d](/filings/0001309402-26-000019.md) | [3.0](/filings/0001309402-26-000060.md) | [41.6](/filings/0001628280-26-054377.md) | [52.2](/filings/0001309402-25-000163.md) | [40.2 d](/filings/0001309402-26-000019.md) | [87.9](/filings/0001309402-26-000060.md) | [113](/filings/0001628280-26-054377.md) |
| Selling, general and administrative | $m | [35.3](/filings/0001309402-24-000129.md) | [32.8 d](/filings/0001309402-26-000019.md) | [31.8](/filings/0001309402-25-000089.md) | [34.0](/filings/0001309402-25-000130.md) | [26.7](/filings/0001309402-25-000163.md) | [25.6 d](/filings/0001309402-26-000019.md) | [42.9](/filings/0001309402-26-000060.md) | [27.6](/filings/0001628280-26-054377.md) | [29.3](/filings/0001309402-25-000163.md) | [22.9 d](/filings/0001309402-26-000019.md) | [19.5](/filings/0001309402-26-000060.md) | [21.7](/filings/0001628280-26-054377.md) |
| Operating income | $m | [21.2](/filings/0001309402-24-000129.md) | [16.3 d](/filings/0001309402-26-000019.md) | [(44.9)](/filings/0001309402-25-000089.md) | [(17.7)](/filings/0001309402-25-000130.md) | [56.1](/filings/0001309402-25-000163.md) | [(40.9) d](/filings/0001309402-26-000019.md) | [(62.3)](/filings/0001309402-26-000060.md) | [(28.4)](/filings/0001628280-26-054377.md) | [33.9](/filings/0001309402-25-000163.md) | [(10.5) d](/filings/0001309402-26-000019.md) | [44.8](/filings/0001309402-26-000060.md) | [67.9](/filings/0001628280-26-054377.md) |
| Interest expense | $m | [9.6](/filings/0001309402-23-000156.md) | [8.7 d](/filings/0001309402-24-000023.md) | [7.8](/filings/0001309402-24-000092.md) | [7.5](/filings/0001309402-25-000130.md) | [10.1](/filings/0001309402-25-000163.md) | [7.7 d](/filings/0001309402-26-000019.md) | [8.9](/filings/0001309402-26-000060.md) | [13.9](/filings/0001628280-26-054377.md) | [47.8](/filings/0001309402-25-000163.md) | [6.1 d](/filings/0001309402-26-000019.md) | [11.5](/filings/0001309402-26-000060.md) | [8.1](/filings/0001628280-26-054377.md) |
| Income tax | $m | [(7.8)](/filings/0001309402-24-000129.md) | [(0.3) d](/filings/0001309402-26-000019.md) | [0.3](/filings/0001309402-25-000089.md) | [(0.3)](/filings/0001309402-25-000130.md) | [(0.8)](/filings/0001309402-25-000163.md) | [7.0 d](/filings/0001309402-26-000019.md) | [0.1](/filings/0001309402-26-000060.md) | [2.3](/filings/0001628280-26-054377.md) | [(25.6)](/filings/0001309402-25-000163.md) | [(28.5) d](/filings/0001309402-26-000019.md) | [2.9](/filings/0001309402-26-000060.md) | [(5.5)](/filings/0001628280-26-054377.md) |
| Net income | $m | [22.3](/filings/0001309402-24-000129.md) | [7.2 d](/filings/0001309402-26-000019.md) | [(51.4)](/filings/0001309402-25-000089.md) | [(24.4)](/filings/0001309402-25-000130.md) | [48.2](/filings/0001309402-25-000163.md) | [(54.9) d](/filings/0001309402-26-000019.md) | [(72.9)](/filings/0001309402-26-000060.md) | [(72.2)](/filings/0001628280-26-054377.md) | [11.9](/filings/0001309402-25-000163.md) | [11.9 d](/filings/0001309402-26-000019.md) | [32.9](/filings/0001309402-26-000060.md) | [67.1](/filings/0001628280-26-054377.md) |
| Diluted EPS | $ per share | [0.35](/filings/0001309402-24-000129.md) | not reported | [(0.81)](/filings/0001309402-25-000089.md) | [(0.38)](/filings/0001309402-25-000130.md) | [0.69](/filings/0001309402-25-000163.md) | not reported | [(1.14)](/filings/0001309402-26-000060.md) | [(1.09)](/filings/0001628280-26-054377.md) | [0.17](/filings/0001309402-25-000163.md) | not reported | [0.42](/filings/0001309402-26-000060.md) | [0.83](/filings/0001628280-26-054377.md) |
| Basic EPS | $ per share | [0.38](/filings/0001309402-24-000129.md) | not reported | [(0.81)](/filings/0001309402-25-000089.md) | [(0.38)](/filings/0001309402-25-000130.md) | [0.75](/filings/0001309402-25-000163.md) | not reported | [(1.14)](/filings/0001309402-26-000060.md) | [(1.09)](/filings/0001628280-26-054377.md) | [0.17](/filings/0001309402-25-000163.md) | not reported | [0.48](/filings/0001309402-26-000060.md) | [0.97](/filings/0001628280-26-054377.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [327](/filings/0001309402-23-000156.md) | [350](/filings/0001309402-25-000008.md) | [237](/filings/0001309402-24-000092.md) | [196](/filings/0001309402-24-000114.md) | [227](/filings/0001309402-24-000129.md) | [173](/filings/0001309402-26-000019.md) | [98.6](/filings/0001309402-25-000089.md) | [109](/filings/0001309402-25-000130.md) | [136](/filings/0001309402-25-000163.md) | [182](/filings/0001628280-26-054377.md) | [95.7](/filings/0001309402-26-000060.md) | [185](/filings/0001628280-26-054377.md) |
| Current assets | $m | [758](/filings/0001309402-23-000156.md) | [733](/filings/0001309402-25-000008.md) | [588](/filings/0001309402-24-000092.md) | [552](/filings/0001309402-24-000114.md) | [561](/filings/0001309402-24-000129.md) | [569](/filings/0001309402-26-000019.md) | [450](/filings/0001309402-25-000089.md) | [436](/filings/0001309402-25-000130.md) | [447](/filings/0001309402-25-000163.md) | [523](/filings/0001628280-26-054377.md) | [542](/filings/0001309402-26-000060.md) | [625](/filings/0001628280-26-054377.md) |
| Total assets | $m | [1,951](/filings/0001309402-23-000156.md) | [1,939](/filings/0001309402-25-000008.md) | [1,799](/filings/0001309402-24-000092.md) | [1,764](/filings/0001309402-24-000114.md) | [1,760](/filings/0001309402-24-000129.md) | [1,782](/filings/0001309402-26-000019.md) | [1,667](/filings/0001309402-25-000089.md) | [1,613](/filings/0001309402-25-000130.md) | [1,532](/filings/0001309402-25-000163.md) | [1,585](/filings/0001628280-26-054377.md) | [1,587](/filings/0001309402-26-000060.md) | [1,657](/filings/0001628280-26-054377.md) |
| Current liabilities | $m | [402](/filings/0001309402-23-000156.md) | [385](/filings/0001309402-25-000008.md) | [336](/filings/0001309402-24-000092.md) | [328](/filings/0001309402-24-000114.md) | [316](/filings/0001309402-24-000129.md) | [386](/filings/0001309402-26-000019.md) | [326](/filings/0001309402-25-000089.md) | [297](/filings/0001309402-25-000130.md) | [266](/filings/0001309402-25-000163.md) | [269](/filings/0001628280-26-054377.md) | [318](/filings/0001309402-26-000060.md) | [314](/filings/0001628280-26-054377.md) |
| Total liabilities | $m | [977](/filings/0001309402-23-000156.md) | [949](/filings/0001309402-25-000008.md) | [899](/filings/0001309402-24-000092.md) | [883](/filings/0001309402-24-000114.md) | [821](/filings/0001309402-24-000129.md) | [908](/filings/0001309402-26-000019.md) | [859](/filings/0001309402-25-000089.md) | [872](/filings/0001309402-25-000130.md) | [758](/filings/0001309402-25-000163.md) | [813](/filings/0001628280-26-054377.md) | [796](/filings/0001309402-26-000060.md) | [787](/filings/0001628280-26-054377.md) |
| Long-term debt | $m | [492](/filings/0001309402-23-000156.md) | [492](/filings/0001309402-25-000008.md) | [490](/filings/0001309402-24-000092.md) | [484](/filings/0001309402-24-000114.md) | [431](/filings/0001309402-24-000129.md) | [432](/filings/0001309402-26-000019.md) | [432](/filings/0001309402-25-000089.md) | [426](/filings/0001309402-25-000130.md) | [306](/filings/0001309402-25-000163.md) | [362](/filings/0001628280-26-054377.md) | [389](/filings/0001309402-26-000060.md) | [387](/filings/0001628280-26-054377.md) |
| Current portion of debt | $m | [1.9](/filings/0001309402-23-000156.md) | [1.8](/filings/0001309402-25-000008.md) | [1.8](/filings/0001309402-24-000092.md) | [1.8](/filings/0001309402-24-000114.md) | [1.9](/filings/0001309402-24-000129.md) | [2.1](/filings/0001309402-26-000019.md) | [2.1](/filings/0001309402-25-000089.md) | [2.1](/filings/0001309402-25-000130.md) | [2.0](/filings/0001309402-25-000163.md) | [3.9](/filings/0001628280-26-054377.md) | [69.3](/filings/0001309402-26-000060.md) | [69.5](/filings/0001628280-26-054377.md) |
| Short-term borrowings | $m | [160](/filings/0001309402-23-000156.md) | [106](/filings/0001309402-25-000008.md) | [130](/filings/0001309402-24-000092.md) | [125](/filings/0001309402-24-000114.md) | [123](/filings/0001309402-24-000129.md) | [141](/filings/0001309402-26-000019.md) | [137](/filings/0001309402-25-000089.md) | [80.1](/filings/0001309402-25-000130.md) | [45.0](/filings/0001309402-25-000163.md) | [33.6](/filings/0001628280-26-054377.md) | [34.0](/filings/0001309402-26-000060.md) | [27.0](/filings/0001628280-26-054377.md) |
| Shareholders' equity | $m | [828](/filings/0001309402-23-000156.md) | [844](/filings/0001309402-25-000008.md) | [887](/filings/0001309402-24-000092.md) | [867](/filings/0001309402-24-000114.md) | [926](/filings/0001309402-24-000129.md) | [865](/filings/0001309402-26-000019.md) | [798](/filings/0001309402-25-000089.md) | [735](/filings/0001309402-25-000130.md) | [769](/filings/0001309402-25-000163.md) | [766](/filings/0001628280-26-054377.md) | [785](/filings/0001309402-26-000060.md) | [870](/filings/0001628280-26-054377.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [113 d](/filings/0001309402-24-000129.md) | [112 d](/filings/0001309402-26-000019.md) | [(50.6)](/filings/0001309402-25-000089.md) | [(15.1) d](/filings/0001309402-25-000130.md) | [62.7 d](/filings/0001309402-25-000163.md) | [(27.0) d](/filings/0001309402-26-000019.md) | [(55.0)](/filings/0001309402-26-000060.md) | [58.8 d](/filings/0001628280-26-054377.md) | [39.8 d](/filings/0001309402-25-000163.md) | [67.3 d](/filings/0001309402-26-000019.md) | [(39.5)](/filings/0001309402-26-000060.md) | [86.3 d](/filings/0001628280-26-054377.md) |
| Capital expenditure | $m | [29.0 d](/filings/0001309402-24-000129.md) | [30.2 d](/filings/0001309402-26-000019.md) | [21.8](/filings/0001309402-25-000089.md) | [17.7 d](/filings/0001309402-25-000130.md) | [28.3 d](/filings/0001309402-25-000163.md) | [27.3 d](/filings/0001309402-26-000019.md) | [16.7](/filings/0001309402-26-000060.md) | [11.1 d](/filings/0001628280-26-054377.md) | [4.0 d](/filings/0001309402-25-000163.md) | [5.3 d](/filings/0001309402-26-000019.md) | [6.4](/filings/0001309402-26-000060.md) | [10.7 d](/filings/0001628280-26-054377.md) |
| Dividends paid | $m | [5.7 d](/filings/0001309402-24-000129.md) | [5.3 d](/filings/0001309402-26-000019.md) | [0.0](/filings/0001309402-24-000092.md) | [0.0 d](/filings/0001309402-24-000114.md) | [0.0 d](/filings/0001309402-24-000129.md) | [5.2 d](/filings/0001309402-26-000019.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [57.7](/filings/0001309402-23-000156.md) | [58.5](/filings/0001309402-24-000092.md) | [58.9](/filings/0001309402-24-000114.md) | [67.4](/filings/0001309402-24-000129.md) | [63.3](/filings/0001309402-25-000089.md) | [63.9](/filings/0001309402-25-000130.md) | [71.7](/filings/0001309402-25-000163.md) | [64.1](/filings/0001309402-26-000060.md) | [66.5](/filings/0001628280-26-054377.md) | [77.9](/filings/0001309402-25-000163.md) | [84.1](/filings/0001309402-26-000060.md) | [84.5](/filings/0001628280-26-054377.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 70,095,328 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-054377.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.